This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nutrien (NTR) Declares TSX Clearance of Shares Buyback Program
by Zacks Equity Research
Nutrien (NTR) receives approval for a new share repurchase program, allowing it to buy back up to 5% of outstanding shares to return capital to shareholders.
Nutrien (NTR) Ups Quarterly Dividend, Announces Share Buyback
by Zacks Equity Research
The board of Nutrien (NTR) authorizes the purchase of up to 5% of the company's issued and outstanding common shares over a 12-month period.
Nutrien's (NTR) Q4 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Nutrien (NTR) earnings miss and sales beat their respective estimates amid lower selling prices across all segments in Q4.
Nutrien (NTR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nutrien (NTR) Q4 Earnings Lag Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -48.61% and 8.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Nutrien (NTR) This Earnings Season?
by Zacks Equity Research
Nutrien (NTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nutrien (NTR) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien (NTR) is expected to have benefited from healthy demand for fertilizers and its cost and operational efficiency initiatives amid headwinds from weaker prices in Q4.
Celanese (CE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q4.
Mosaic (MOS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) Q4 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
Curious about Nutrien (NTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Nutrien (NTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Nutrien (NTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nutrien (NTR) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Nutrien (NTR) closed at $50.06 in the latest trading session, marking a +1.93% move from the prior day.
Barrick (GOLD) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Barrick's (GOLD) fourth-quarter results are expected to have benefited from sequentially higher gold production and prices.
Albemarle (ALB) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost-reduction actions in Q4 amid demand headwinds in specialties.
CF Industries (CF) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
CF Industries' (CF) fourth-quarter results are likely to reflect the impacts of softer nitrogen prices.
Scotts Miracle-Gro (SMG) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 10.49% and 3.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Nutrien (NTR) reachead $50.12 at the closing of the latest trading day, reflecting a -1.71% change compared to its last close.
DuPont (DD) Warms Up to Q4 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont's (DD) fourth-quarter results are likely to reflect the impacts of demand softness and inventory de-stocking.
Air Products (APD) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Air Products (APD) is expected to have gained from cost-improvement and productivity initiatives, higher volumes in Americas and pricing actions in Q1.
U.S. Steel (X) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
U.S. Steel's (X) fourth-quarter results are likely to have been impacted by weaker selling prices across its segments.
LyondellBasell (LYB) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Weaker demand in most industries and higher feedstock and energy costs are likely to have impacted LyondellBasell's (LYB) fourth-quarter results.
Here's Why Nutrien (NTR) Gained But Lagged the Market Today
by Zacks Equity Research
In the most recent trading session, Nutrien (NTR) closed at $51.18, indicating a +0.63% shift from the previous trading day.
Eastman Chemical (EMN) to Post Q4 Earnings: Factors at Play
by Zacks Equity Research
Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives as well as its innovation initiatives amid demand headwinds in Q4.
Nutrien (NTR) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Nutrien (NTR) closed at $51.05, indicating a -0.78% shift from the previous trading day.
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
by Zacks Equity Research
While Nutrien (NTR) faces challenges from softer fertilizer prices, it gains on strong demand for crop nutrients on the strength in global agriculture markets.